REVIVION Trademark

Trademark Overview


On Monday, June 15, 2026, a trademark application was filed for REVIVION with the United States Patent and Trademark Office. The USPTO has given the REVIVION trademark a serial number of 99886336. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 15, 2026. This trademark is owned by PetVivo Holdings, Inc.. The REVIVION trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Biomaterials derived from natural components, and biomaterials comprised of naturally derived and synthetic materials, namely, hydrogels, microparticles, particulates, fibers, sheets, plugs, threads, scaffolds, matrices, membranes, patches, films, carrier materials, electroactive materials, piezoelectric materials, and composite biomaterials for medical and veterinary purposes, namely, for tissue repair, tissue remodeling, tissue restoration, tissue engineering, wound care, soft tissue augmentation, cartilage repair, orthopedic joint preservation, cardiovascular treatment, treatment of musculoskeletal disorders, pain reduction, cosmetic and aesthetic applications, and the delivery, controlled release, localization, or administration of pharmaceuticals, biologics, therapeutic agents, cells, proteins, peptides, growth factors, nucleic acids, and other bioactive substances.

Medical and veterinary devices, namely, injectable and implantable medical devices, implants, scaffolds, cellular matrix scaffolds, matrices, membranes, patches, films, sheets, plugs, threads, fibers, and carrier materials for tissue repair, tissue remodeling, tissue restoration, tissue engineering, wound healing, soft tissue augmentation, cartilage repair, orthopedic joint preservation, cardiovascular treatment, treatment of musculoskeletal disorders, pain reduction, cosmetic and aesthetic applications, and the delivery, controlled release, localization, or administration of pharmaceuticals, biologics, therapeutic agents, cells, proteins, peptides, growth factors, nucleic acids, and other bioactive substances; medical implants made of artificial materials for supporting, reinforcing, augmenting, repairing, replacing, remodeling, restoring, or regenerating tissue and anatomical structures; electroactive and piezoelectric medical devices for biostimulation, tissue stimulation, tissue re...
revivion

General Information


Serial Number99886336
Word MarkREVIVION
Filing DateMonday, June 15, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, June 15, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkREVISION
Pseudo MarkREVIVION
Goods and ServicesBiomaterials derived from natural components, and biomaterials comprised of naturally derived and synthetic materials, namely, hydrogels, microparticles, particulates, fibers, sheets, plugs, threads, scaffolds, matrices, membranes, patches, films, carrier materials, electroactive materials, piezoelectric materials, and composite biomaterials for medical and veterinary purposes, namely, for tissue repair, tissue remodeling, tissue restoration, tissue engineering, wound care, soft tissue augmentation, cartilage repair, orthopedic joint preservation, cardiovascular treatment, treatment of musculoskeletal disorders, pain reduction, cosmetic and aesthetic applications, and the delivery, controlled release, localization, or administration of pharmaceuticals, biologics, therapeutic agents, cells, proteins, peptides, growth factors, nucleic acids, and other bioactive substances.
Goods and ServicesMedical and veterinary devices, namely, injectable and implantable medical devices, implants, scaffolds, cellular matrix scaffolds, matrices, membranes, patches, films, sheets, plugs, threads, fibers, and carrier materials for tissue repair, tissue remodeling, tissue restoration, tissue engineering, wound healing, soft tissue augmentation, cartilage repair, orthopedic joint preservation, cardiovascular treatment, treatment of musculoskeletal disorders, pain reduction, cosmetic and aesthetic applications, and the delivery, controlled release, localization, or administration of pharmaceuticals, biologics, therapeutic agents, cells, proteins, peptides, growth factors, nucleic acids, and other bioactive substances; medical implants made of artificial materials for supporting, reinforcing, augmenting, repairing, replacing, remodeling, restoring, or regenerating tissue and anatomical structures; electroactive and piezoelectric medical devices for biostimulation, tissue stimulation, tissue repair, tissue remodeling, tissue restoration, wound healing, cartilage repair, orthopedic treatment, cardiovascular treatment, and tissue engineering applications.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 15, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, June 15, 2026
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePetVivo Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdina, MN 55439
US

Trademark Events


Event DateEvent Description
Monday, June 15, 2026NEW APPLICATION ENTERED
Monday, June 15, 2026APPLICATION FILING RECEIPT MAILED